Frankfurt - Delayed Quote EUR
Sprint Bioscience AB (publ) (5JA1.F)
0.0506
+0.0096
+(23.41%)
As of 9:16:58 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2021
12/31/2020
Operating Cash Flow
-23,356
-23,356
22,871
-40,117
-32,223
Investing Cash Flow
-1,297
-1,297
-2,454
-2,707
--
Financing Cash Flow
-225
-225
24
86,393
50,918
End Cash Position
25,056
25,056
49,934
70,644
27,075
Capital Expenditure
-1,297
-1,297
-2,454
-2,707
--
Issuance of Capital Stock
--
--
2
88,803
48,933
Issuance of Debt
--
--
--
10,000
10,000
Free Cash Flow
-24,653
-24,653
20,417
-42,824
-32,223
12/31/2020 - 8/6/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade